• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于危重症患者短暂性和持续性急性肾损伤诊断评估的尿液生物标志物IGFBP7和TIMP-2

Urinary Biomarkers IGFBP7 and TIMP-2 for the Diagnostic Assessment of Transient and Persistent Acute Kidney Injury in Critically Ill Patients.

作者信息

Daubin Delphine, Cristol Jean Paul, Dupuy Anne Marie, Kuster Nils, Besnard Noémie, Platon Laura, Buzançais Aurèle, Brunot Vincent, Garnier Fanny, Jonquet Olivier, Klouche Kada

机构信息

Department of Intensive Care Medicine, Lapeyronie University Hospital, Montpellier, France.

Department of Biochemistry, Lapeyronie University Hospital, Montpellier, France.

出版信息

PLoS One. 2017 Jan 13;12(1):e0169674. doi: 10.1371/journal.pone.0169674. eCollection 2017.

DOI:10.1371/journal.pone.0169674
PMID:28085896
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5234791/
Abstract

OBJECTIVE

The capability of urinary TIMP-2 (tissue inhibitor of metalloproteinase) and IGFBP7 (insulin-like growth factor binding protein)-NephroCheck Test (NC) = ([TIMP-2] x [IGFBP7]) / 1000)-to predict renal recovery from acute kidney injury (AKI) has been poorly studied. The aim of this study was to assess the performance of measurements of ([TIMP-2] x [IGFBP7]) / 1000) over 24 hours to differentiate transient from persistent AKI.

METHODS

Of 460 consecutive adult patients admitted to the ICU, 101 were prospectively studied: 56 men, 62 (52-71) years old. A fresh urine sample was collected at H0, H4, H12 and H24 to determine ([TIMP-2] x [IGFBP7]) / 1000) levels. Areas under the curves of Delta NC H4-Ho and H12-H4 and serum creatinine (sCr) for detection of AKI recovery were compared.

RESULTS

Forty-one (40.6%) patient were diagnosed with AKI: 27 transient and 14 persistent AKI. At admission (H0), AKI patients had a significantly higher NC score than patients without AKI (0.43 [0.07-2.06] vs 0.15 [0.07-0.35], p = 0.027). In AKI groups, transient AKI have a higher NC, at H0 and H4, than persistent AKI (0.87 [0.09-2.82] vs 0.13 [0.05-0.66] p = 0.035 and 0.13 [0.07-0.61] vs 0.05 [0.02-0.13] p = 0.013). Thereafter, NC level decreased in both AKI groups with a Delta NC score H4-H0 and H12-H4 significantly more important in transient AKI. Roc curves showed however that delta NC scores did not discriminate between transient and persistent AKI.

CONCLUSION

In our population, absolute urinary levels of NC score were higher at early hours after ICU admission (H0 and H4) in transient AKI as compared to persistent AKI patients. NC variations (Delta NC scores) over the first 12 hours may indicate the AKI's evolving nature with a more significant decrease in case of transient AKI but were not able to differentiate transient from persistent AKI.

摘要

目的

尿组织金属蛋白酶抑制剂-2(TIMP-2)和胰岛素样生长因子结合蛋白7(IGFBP7)-肾损伤检测试验(NC)=([TIMP-2]×[IGFBP7])/1000预测急性肾损伤(AKI)后肾功能恢复的能力研究较少。本研究旨在评估24小时内([TIMP-2]×[IGFBP7])/1000的测量结果区分短暂性AKI和持续性AKI的性能。

方法

在入住重症监护病房(ICU)的460例连续成年患者中,前瞻性研究了101例:56例男性,年龄62(52 - 71)岁。在H0、H4、H12和H24采集新鲜尿液样本,以测定([TIMP-2]×[IGFBP7])/1000水平。比较Delta NC H4 - H0和H12 - H4以及血清肌酐(sCr)检测AKI恢复的曲线下面积。

结果

41例(40.6%)患者被诊断为AKI:27例短暂性AKI和14例持续性AKI。入院时(H0),AKI患者的NC评分显著高于无AKI患者(0.43[0.07 - 2.06]对0.15[0.07 - 0.35],p = 0.027)。在AKI组中,短暂性AKI在H(0)和H4时的NC高于持续性AKI(0.87[0.09 - 2.82]对0.13[0.05 - 0.66],p = 0.035;0.13[0.07 - 0.61]对0.05[0.02 - 0.13],p = 0.013)。此后,两组AKI患者的NC水平均下降,短暂性AKI的Delta NC评分H4 - H0和H12 - H4显著更高。然而,Roc曲线显示Delta NC评分无法区分短暂性AKI和持续性AKI。

结论

在我们的研究人群中,与持续性AKI患者相比,短暂性AKI患者在入住ICU后的早期(H0和H4)尿NC评分的绝对水平更高。最初12小时内NC的变化(Delta NC评分)可能表明AKI的演变性质,短暂性AKI时下降更显著,但无法区分短暂性AKI和持续性AKI。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f76/5234791/83bad80059f5/pone.0169674.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f76/5234791/d4cf6a350ba3/pone.0169674.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f76/5234791/ba489a38df55/pone.0169674.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f76/5234791/9d99e29d5a77/pone.0169674.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f76/5234791/83bad80059f5/pone.0169674.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f76/5234791/d4cf6a350ba3/pone.0169674.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f76/5234791/ba489a38df55/pone.0169674.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f76/5234791/9d99e29d5a77/pone.0169674.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f76/5234791/83bad80059f5/pone.0169674.g004.jpg

相似文献

1
Urinary Biomarkers IGFBP7 and TIMP-2 for the Diagnostic Assessment of Transient and Persistent Acute Kidney Injury in Critically Ill Patients.用于危重症患者短暂性和持续性急性肾损伤诊断评估的尿液生物标志物IGFBP7和TIMP-2
PLoS One. 2017 Jan 13;12(1):e0169674. doi: 10.1371/journal.pone.0169674. eCollection 2017.
2
Urinary Tissue Inhibitor of Metalloproteinase-2 (TIMP-2) • Insulin-Like Growth Factor-Binding Protein 7 (IGFBP7) Predicts Adverse Outcome in Pediatric Acute Kidney Injury.尿金属蛋白酶组织抑制剂-2(TIMP-2)•胰岛素样生长因子结合蛋白7(IGFBP7)可预测小儿急性肾损伤的不良结局。
PLoS One. 2015 Nov 25;10(11):e0143628. doi: 10.1371/journal.pone.0143628. eCollection 2015.
3
Validation of cell-cycle arrest biomarkers for acute kidney injury using clinical adjudication.采用临床裁决验证细胞周期停滞生物标志物在急性肾损伤中的应用。
Am J Respir Crit Care Med. 2014 Apr 15;189(8):932-9. doi: 10.1164/rccm.201401-0077OC.
4
A combined approach for the early recognition of acute kidney injury after adult cardiac surgery.成人心脏手术后急性肾损伤的早期识别的综合方法。
Anaesth Crit Care Pain Med. 2018 Aug;37(4):335-341. doi: 10.1016/j.accpm.2018.05.001. Epub 2018 May 17.
5
Early prediction of acute kidney injury after transapical and transaortic aortic valve implantation with urinary G1 cell cycle arrest biomarkers.利用尿液G1细胞周期阻滞生物标志物对经心尖和经主动脉主动脉瓣植入术后急性肾损伤进行早期预测。
BMC Anesthesiol. 2016 Sep 8;16:76. doi: 10.1186/s12871-016-0244-8.
6
Urine Biomarkers of Tubular Renal Cell Damage for the Prediction of Acute Kidney Injury After Cardiac Surgery-A Pilot Study.用于预测心脏手术后急性肾损伤的肾小管肾细胞损伤尿液生物标志物——一项初步研究
J Cardiothorac Vasc Anesth. 2017 Dec;31(6):2072-2079. doi: 10.1053/j.jvca.2017.04.024. Epub 2017 Apr 16.
7
Cisplatin nephrotoxicity is not detected by urinary cell-cycle arrest biomarkers in lung cancer patients.肺癌患者的尿细胞周期停滞生物标志物未检测到顺铂肾毒性。
Int Urol Nephrol. 2017 Jun;49(6):1041-1047. doi: 10.1007/s11255-017-1556-4. Epub 2017 Mar 2.
8
Tissue inhibitor metalloproteinase-2 (TIMP-2) • IGF-binding protein-7 (IGFBP7) levels are associated with adverse outcomes in patients in the intensive care unit with acute kidney injury.组织金属蛋白酶抑制剂 2(TIMP-2) • 胰岛素样生长因子结合蛋白 7(IGFBP7)水平与重症监护病房急性肾损伤患者的不良预后相关。
Kidney Int. 2019 Jun;95(6):1486-1493. doi: 10.1016/j.kint.2019.01.020. Epub 2019 Mar 9.
9
Urinary biomarkers TIMP-2 and IGFBP7 early predict acute kidney injury after major surgery.尿液生物标志物TIMP-2和IGFBP7可早期预测大手术后的急性肾损伤。
PLoS One. 2015 Mar 23;10(3):e0120863. doi: 10.1371/journal.pone.0120863. eCollection 2015.
10
Urinary TIMP-2 and IGFBP7 as early biomarkers of acute kidney injury and renal recovery following cardiac surgery.尿组织金属蛋白酶抑制因子-2和胰岛素样生长因子结合蛋白7作为心脏手术后急性肾损伤及肾脏恢复的早期生物标志物。
PLoS One. 2014 Mar 27;9(3):e93460. doi: 10.1371/journal.pone.0093460. eCollection 2014.

引用本文的文献

1
The efficacy of novel biomarkers for the early detection and management of acute kidney injury: A systematic review.新型生物标志物在急性肾损伤早期检测与管理中的效能:一项系统综述。
PLoS One. 2025 Jan 29;20(1):e0311755. doi: 10.1371/journal.pone.0311755. eCollection 2025.
2
Tissue Inhibitor of Metalloproteinases-2 (TIMP-2) as a Prognostic Biomarker in Acute Kidney Injury: A Narrative Review.金属蛋白酶组织抑制剂-2(TIMP-2)作为急性肾损伤的预后生物标志物:一项叙述性综述
Diagnostics (Basel). 2024 Jun 25;14(13):1350. doi: 10.3390/diagnostics14131350.
3
The TIMP protein family: diverse roles in pathophysiology.

本文引用的文献

1
Kinetic eGFR and Novel AKI Biomarkers to Predict Renal Recovery.预测肾脏恢复的动态估算肾小球滤过率和新型急性肾损伤生物标志物
Clin J Am Soc Nephrol. 2015 Nov 6;10(11):1900-10. doi: 10.2215/CJN.12651214. Epub 2015 Sep 4.
2
Cell-cycle arrest and acute kidney injury: the light and the dark sides.细胞周期阻滞与急性肾损伤:光明与黑暗面
Nephrol Dial Transplant. 2016 Jan;31(1):16-22. doi: 10.1093/ndt/gfv130. Epub 2015 Jun 4.
3
Effect of remote ischemic preconditioning on kidney injury among high-risk patients undergoing cardiac surgery: a randomized clinical trial.
TIMP 蛋白家族:在病理生理学中的多种作用。
Am J Physiol Cell Physiol. 2024 Mar 1;326(3):C917-C934. doi: 10.1152/ajpcell.00699.2023. Epub 2024 Jan 29.
4
Update on prognosis driven classification of pediatric AKI.儿童急性肾损伤预后驱动分类的最新进展。
Front Pediatr. 2022 Oct 21;10:1039024. doi: 10.3389/fped.2022.1039024. eCollection 2022.
5
Improving acute kidney injury diagnostic precision using biomarkers.使用生物标志物提高急性肾损伤的诊断精度。
Pract Lab Med. 2022 Apr 9;30:e00272. doi: 10.1016/j.plabm.2022.e00272. eCollection 2022 May.
6
Real-Time Prediction of Acute Kidney Injury in Hospitalized Adults: Implementation and Proof of Concept.实时预测住院成人急性肾损伤:实施与概念验证。
Am J Kidney Dis. 2020 Dec;76(6):806-814.e1. doi: 10.1053/j.ajkd.2020.05.003. Epub 2020 Jun 4.
7
Urine cell cycle arrest biomarkers distinguish poorly between transient and persistent AKI in early septic shock: a prospective, multicenter study.尿细胞周期停滞生物标志物不能区分早期感染性休克时短暂性和持续性急性肾损伤:一项前瞻性、多中心研究。
Crit Care. 2020 Jun 1;24(1):280. doi: 10.1186/s13054-020-02984-6.
8
Perioperative Acute Kidney Injury.围手术期急性肾损伤。
Anesthesiology. 2020 Jan;132(1):180-204. doi: 10.1097/ALN.0000000000002968.
9
Mechanisms Underlying Increased TIMP2 and IGFBP7 Urinary Excretion in Experimental AKI.实验性 AKI 中 TIMP2 和 IGFBP7 尿排泄增加的机制。
J Am Soc Nephrol. 2018 Aug;29(8):2157-2167. doi: 10.1681/ASN.2018030265. Epub 2018 Jul 6.
10
The urine biomarker panel [IGFBP7]x[TIMP-2] (NephroCheck® parameter) does not correlate with IGFBP7 and TIMP-2 gene expression in urinary sediment.尿液生物标志物组合[胰岛素样生长因子结合蛋白7]×[基质金属蛋白酶组织抑制因子-2](NephroCheck®参数)与尿沉渣中胰岛素样生长因子结合蛋白7和基质金属蛋白酶组织抑制因子-2的基因表达不相关。
PLoS One. 2017 Nov 16;12(11):e0188316. doi: 10.1371/journal.pone.0188316. eCollection 2017.
远程缺血预处理对高危心脏手术患者肾损伤的影响:一项随机临床试验。
JAMA. 2015 Jun 2;313(21):2133-41. doi: 10.1001/jama.2015.4189.
4
Transient and Persistent Acute Kidney Injury and the Risk of Hospital Mortality in Critically Ill Patients: Results of a Multicenter Cohort Study.危重症患者急性肾损伤的一过性和持续性与住院死亡率的关系:一项多中心队列研究的结果。
Crit Care Med. 2015 Aug;43(8):e269-75. doi: 10.1097/CCM.0000000000001077.
5
Assessment of cell-cycle arrest biomarkers to predict early and delayed acute kidney injury.评估细胞周期阻滞生物标志物以预测早期和延迟性急性肾损伤。
Dis Markers. 2015;2015:158658. doi: 10.1155/2015/158658. Epub 2015 Mar 18.
6
Quantification of urinary TIMP-2 and IGFBP-7: an adequate diagnostic test to predict acute kidney injury after cardiac surgery?尿组织金属蛋白酶抑制剂-2(TIMP-2)和胰岛素样生长因子结合蛋白-7(IGFBP-7)的定量检测:预测心脏手术后急性肾损伤的充分诊断试验?
Crit Care. 2015 Jan 6;19(1):3. doi: 10.1186/s13054-014-0717-4.
7
Evaluation of urinary tissue inhibitor of metalloproteinase-2 in acute kidney injury: a prospective observational study.急性肾损伤中尿金属蛋白酶组织抑制剂-2的评估:一项前瞻性观察研究。
Crit Care. 2014 Dec 19;18(6):716. doi: 10.1186/s13054-014-0716-5.
8
Failure of renal biomarkers to predict worsening renal function in high-risk patients presenting with oliguria.在伴有少尿的高危患者中,肾生物标志物预测肾功能恶化的失败。
Intensive Care Med. 2015 Jan;41(1):68-76. doi: 10.1007/s00134-014-3566-3. Epub 2014 Dec 3.
9
Derivation and validation of cutoffs for clinical use of cell cycle arrest biomarkers.细胞周期阻滞生物标志物临床应用临界值的推导与验证
Nephrol Dial Transplant. 2014 Nov;29(11):2054-61. doi: 10.1093/ndt/gfu292. Epub 2014 Sep 18.
10
Urinary TIMP-2 and IGFBP7 as early biomarkers of acute kidney injury and renal recovery following cardiac surgery.尿组织金属蛋白酶抑制因子-2和胰岛素样生长因子结合蛋白7作为心脏手术后急性肾损伤及肾脏恢复的早期生物标志物。
PLoS One. 2014 Mar 27;9(3):e93460. doi: 10.1371/journal.pone.0093460. eCollection 2014.